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calmodulin, activates the biosynthetic activity of NOS
(Bredt and Snyder, 1990).
Because NO lacks vesicular storage and depends on
new synthesis for its release, nNOS must be associated
with the plasma membrane. Subcellular fractionation
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Departments of Neuroscience, Pharmacology indicates that roughly half of brain nNOS is soluble and
half particulate (Hecker et al., 1994; Bredt, 1996). Re-and Molecular Sciences, and Psychiatry
Baltimore, Maryland 21205 cently, Bredt and associates showed that nNOS is tar-
geted to membranes by binding to syntrophin, PSD95/
SAP90, or PSD93 (Brenman et al., 1996a, 1996b). These
proteins are enriched in synaptic densities and interactSummary
with nNOS through PDZ domains, consensus sequences
of about 100 amino acids that are found in proteins thatNitric oxide (NO) produced by neuronal nitric oxide
tend to be associated with cell±cell junctions (Pontingsynthase (nNOS) is important for N-methyl-D-aspar-
and Phillips, 1995). The nNOS/PSD95 interaction in-tate (NMDA) receptor-dependent neurotransmitter re-
volves a portion of nNOS that includes its sole PDZlease, neurotoxicity, and cyclic GMP elevations. The
domain and the second PDZ domain of PSD95. PSD95coupling of NMDA receptor-mediated calcium influx
was first isolated from postsynaptic densities (Cho etand nNOS activation is postulated to be due to a physi-
al., 1992) but also occurs in presynaptic nerve terminalscal coupling of the receptor and the enzyme by an
(Kistner et al., 1993) and clusters neurotransmitter re-intermediary adaptor protein, PSD95, through aunique
ceptors and ion channels at synaptic sites (Kornau etPDZ±PDZ domain interaction between PSD95 and
al., 1997). For instance, the NMDA receptor and severalnNOS. Here, we report the identification of a novel
potassium channels are associated with PSD95 at syn-nNOS-associated protein, CAPON, which is highly en-
apses (Kornau et al., 1995). The linking of NMDA recep-riched in brain and has numerous colocalizations with
tors to nNOS by PSD95 may explain why calcium influxnNOS. CAPON interacts with the nNOS PDZ domain
following NMDA receptor activation leads to a tightlythrough its C terminus. CAPON competes with PSD95
coupled nNOS activation (Brenman et al., 1996a). In-for interaction with nNOS, and overexpression of
deed, the effects of NO appear to be intimately tiedCAPON results in a loss of PSD95/nNOS complexes
to the NMDA receptor. For example, NMDA receptor-in transfected cells. CAPON may influence nNOS by
mediated neurotoxicity (Dawson and Dawson, 1996),regulating its ability to associate with PSD95/NMDA
neurotransmitter release (Schuman and Madison, 1994),receptor complexes.
and cGMP elevations (Bredt and Snyder,1989; Garthwaite
et al., 1989) each require nNOS and are blocked by
Introduction nNOS-specific inhibitors. Moreover, NO can directly mod-
ulate NMDA receptors (Lipton and Stamler, 1994).
Studies of neuronally derived nitric oxide (NO) have re- We wondered whether nNOS binding toother proteins
vealed many roles for this gaseous messenger molecule might regulate its intracellular localization. Accordingly,
(Moncada, 1994; Yun et al., 1996). In the peripheral we conducted a yeast two-hybrid screen in which we
nervous system, NO mediates nonadrenergic, noncho- have identified a novel protein, which we designate
linergic neurotransmission, serving as an effector of au- CAPON (carboxy-terminal PDZ ligand of nNOS). CAPON
tonomic neurons on smooth muscle. NO has been impli- is a cytoplasmic protein whose C terminus binds to the
cated in several forms of neuronal plasticity, such as PDZ domain of nNOS. CAPON competes with PSD95
LTP (for a review, see Huang, 1997). Studies in mice and PSD93 for binding to nNOS and thus mayparticipate
with a targeted genomic deletion of the NO biosynthetic in the translocation and impede the activation of this
enzyme neuronal NO synthase (nNOS) have shown that enzyme.
NO mediates a substantial portion of the neurotoxicity
associated with stroke (Huang et al., 1994). In the brain,
ResultsNO and citrulline are produced from arginine predomi-
nantly by nNOS (Huanget al., 1993), although endothelial
Identification and Cloning of CAPONNOS (eNOS) may also occur in neurons (Dinerman et
We conducted a yeast two-hybrid screen employing theal., 1994; O'Dell et al., 1994). Most neurotransmitters are
first 377 amino acids of nNOS, a region that includesstored in synaptic vesicles, and neurotransmitter effects
the PDZ domain that comprises the first 100 amino acidsare elicited following the exocytosis of transmitter into
of nNOS. Screening of six million clones resulted in thethe synaptic space. For an evanescent transmitter such
identification of three distinct cDNA inserts, one ofas NO, there is no storage pool, and newly synthesized
which, PIN, has been previously reported (Jaffrey andNO is used as it is made. NO synthesis is triggered
Snyder, 1996), while the other two are overlappingby the influx of calcium, which, when complexed with
cDNAs derived from a gene that is designated CAPON.
The CAPON two-hybrid clones share a common C termi-
nus and are predicted to translate into 125 and 327*To whom correspondence should be addressed.
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amino acid peptides followed by a stop codon. The 125
amino acid C-terminal fragment of CAPON specifically
interacts with nNOS in the two-hybrid system as is evi-
dent from the failure of CAPON to interact with frag-
ments of PSD93 and PSD95 containing PDZ domains
(Figure 1A). Moreover, nNOS fails to interact with an-
other control protein, c-fos. To obtain a full-length
CAPON cDNA, we screened a rat brain cDNA library
with the larger two-hybrid clone and isolated a 2100 bp
cDNA that overlapped with the two-hybrid clone and
was used to assemble a final 2820 bp cDNA (see Experi-
mental Procedures). The conceptual translation of this
cDNA produces a 503 amino acid protein (Figure 1B).
The first ATG in the cDNA was 393 bp from the 59 end
of the cDNA and was situated in a context that con-
formed to the Kozak consensus sequence for an initiator
methionine (Kozak, 1991).
CAPON displays no significant homology to any other
known class of protein except for an N-terminal 145
amino acid stretch of amino acids that has residues
suggestive of a phosphotyrosine-binding (PTB) domain
(Zhou et al., 1995). CAPON's PTB domain most closely
resembles the mouse numb protein's PTB domain
(Zhong et al., 1996), with nearly 28% sequence identity
on this region. The similarity between CAPON and numb
is limited to this domain. PTB domains are targeted
to phosphotyrosine-containing proteins such as growth
factor receptors (reviewed in van der Geer and Pawson,
1995).
Outside of the PTB domain, CAPON lacks any well-
known consensus sequences except for an 18 nucleo-
tide stretch of CAG repeats that corresponds to six glu-
tamines. Glutamine repeats occur in proteins whose
expansion results in neurodegenerative diseases as ex-
emplified by huntingtin, the protein that is altered in
Huntington's disease (Ross, 1995). A BLAST search
(Altschul et al., 1990) of an expressed sequence tag
database, dBEST, reveals a human brain-derived EST
with z75% nucleotide identity to CAPON. The cDNA
Figure 1. Cloning of the CAPON cDNA and Distribution of CAPON insert was 1.4 kb and corresponds to the C-terminal
mRNA 156 amino acids of CAPON plus 1 kb of 39 UTR. The
(A) CAPON specifically interacts with nNOS in the yeast two-hybrid conceptual translation of this portion of human CAPON
system. Yeast were transformed with the indicated GAL4 activation has 92% amino acid identity with the rat protein (Fig-
domain (AD) and GAL4 DNA-binding domain (BD) plasmids and
ure 1B).grown on plates containing histidine. A typical filter lift is shown, in
Northern (RNA) blotting reveals a predominant 7.5 kbwhich b-galactosidase activity was detected by the appearance of
transcript that is detected only in brain regions, with noa blue precipitate. pAD-CAPON1, comprising the last 125 amino
acids of CAPON, activates lacZ transcription in the presence of expression evident in adrenal, bladder, heart, kidney,
pBD-nNOS(2±377) but not with plasmids comprising the first three lung, and skeletal muscle (Figure 1C). Marked regional
PDZ domains of PSD95 (amino acids 20±364) or the second PDZ variations occur in the brain, with highest densities in
domain of PSD93 (amino acids 116±421).
the cerebral cortex and medulla-oblongata and lowest(B) Amino acid sequence of rat CAPON and alignment with a partial
levels in the hippocampus.human sequence. The underlined sequence corresponds to the pu-
tative PTB domain. The bracketed sequence is encoded by a CAG
repeat. A human expressed sequence tag (EST) (accession number CAPON and nNOS Interact In Vivo and In Vitro
R19867) obtained from a library derived from infant brain contains To assess the specificity of interactions between
a 459 bp open reading frame with homology to the C terminus of CAPON and nNOS, we evaluated the binding of a GST±
the CAPON cDNA (p 5 5.1 3 10217). The conceptual translation of CAPON fusion protein, consisting of the C-terminal 125
this clone reveals a protein with 92% amino acid identity with the
amino acids of CAPON, with nNOS, eNOS, and induciblerat protein.
NOS (iNOS) (Figure 2A). Lysates of HEK-293 cells trans-(C) CAPON is enriched in neuronal structures. Northern (RNA) blot
fected with expression plasmids for each of the threeanalysis reveals that several CAPON transcripts are present, and
these transcripts are enriched in neuronal tissues. forms of NOS were incubated with GST±CAPON. After
extensive washing of the resin,bound nNOS was detected
by Western blotting with the appropriate isoform-spe-
cific antibody. nNOS interacts strongly with GST±CAPON,
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Figure 2. Interaction of CAPON and nNOS
(A) CAPON binds to nNOS but not eNOS or iNOS. Bacterially expressed GST, GST±PIN, and GST±CAPON were bound to glutathione agarose
and then incubated with lysates of HEK-293 cells transfected with expression plasmids for the indicated isoforms of NOS. After extensive
washing of the resins, bound NOS was detected with isoform-specific antibodies. While nNOS binds to both GST±PIN and GST±CAPON,
neither eNOS or iNOS binds to either protein. Input 5 10% of starting material applied to each resin.
(B) A GST±NOS fusion protein specifically binds to rat brain CAPON. A fusion protein consisting of GST and amino acids 1±100 of nNOS was
bound to glutathione agarose and then incubated with cerebellar supernatants. After extensive washing, CAPON is detected on the NOS resin
but not on the control GST resin. A second z48 kDa band is also detected with this antibody but fails to interact with nNOS. This band may
represent a cross-reactive protein, an alternatively spliced isoform of CAPON, or a degradation product.
(C) CAPON interacts with nNOS directly. HEK-293 lysates transfected with a expression plasmid containing the nNOS cDNA or empty vector
were resolved by electrophoresis, transferred to nitrocellulose, and probed with radiolabeled CAPON (see Experimental Procedures). Purified
nNOS is recognized with this probe, along with a comigrating band detected in NOS-transfected but not mock-transfected cells.
(D) CAPON and nNOS complexes are detectable in cerebellar lysates (I). Cerebellar supernatants were prepared from wild-type (1/1) and
nNOS knockout (2/2) mice and incubated with 29,59-ADP-Sepharose, an nNOS affinity resin. Only CAPON derived from supernatants of wild-
type and not knockout animals was capable of binding the resin, indicating that the presence of nNOS is required for CAPON to bind to the
resin. CAPON levels were decreased in knockout animals, presumably due to decreased stability in the absence of the nNOS-binding partner.
A lower molecular weight band (arrowhead), frequently detected with the anti-CAPON antibody, bound weakly to the resin in an nNOS-specific
manner as well. Input 5 20% of lysate used for binding.
(E) CAPON and nNOS complexes are detectable in cerebellar lysates (II). An antibody to CAPON (5 mg) specifically coprecipitates nNOS, while
comparable amounts of antibody to the G protein subunit b1, cyclin-dependent kinase 2, and preimmune serum fail to coprecipitate nNOS.
Enrichment of nNOS in CAPON immunoprecipitates was specific, as a control protein, protein kinase C-b I/II, did not display similar enrichment.
Input 5 10% of lysate used for immunoprecipitation.
while eNOS and iNOS do not interact. No interactions GST±nNOS fusion proteins (Figure 2B) and may repre-
sent an unrelated cross-reactive protein or the productare evident with the GST control.
We also examined interactions of CAPON and nNOS of an alternatively spliced CAPON mRNA that fails to
bind nNOS.by utilizing a GST fusion protein of the N-terminal 100
amino acids of nNOS, the PDZ domain. Following incu- The protein±protein interactions we detected with cell
lysates and GST fusion proteins may reflect a tertiarybation with cerebellar lysates, the washed GST±nNOS
resin was subjected to SDS-PAGE and Western blotted interaction between nNOS, an unidentified protein, and
CAPON. To determine if CAPON directly binds to nNOS,with a purified antibody directed against the C-terminal
125 amino acids of CAPON. A single band correspond- we conducted blot overlay experiments (Figure 2C).
Lysates of HEK-293 cells transfected with nNOS wereing to CAPON is detected, while no CAPON is bound
to the GST control. A lower molecular weight band in resolved on a polyacrylamide gel, transferred to nitrocel-
lulose, and then probed with [32P]GST±CAPON. The ra-homogenates is occasionally detected using our anti-
CAPON antibodies. This protein fails to interact with diolabeled CAPON probe binds to a single 160 kDa band
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comigrating with an nNOS standard, while no binding cerebral cortex, dentate gyrus of the hippocampus, Is-
lands of Calleja, olfactory bulb, superior colliculus, andis evident in mock transfected cells, demonstrating that
CAPON physically interacts in a direct manner with supraoptic nucleus (Figure 3A) (Bredt et al., 1990; Rod-
rigo et al., 1994). CAPON immunoreactivity displays sim-nNOS.
To ascertain if complexes of CAPON and nNOS exist ilar distributions, with highest levels in the olfactory bulb
and cerebellum like nNOS (Figure 3A). We also localizedphysiologically, we used two approaches. Our first ap-
proach took advantage of a NOS affinity resin consisting CAPON mRNA by in situ hybridization using a probe
directed against the 39 region of the CAPON open read-of 29, 59-ADP ribose crosslinked to an agarose matrix.
This resin has been used previously to purify nNOS from ing frame. CAPON mRNA densities were especially
prominent in the accessory and main olfactory bulbs,cerebellar supernatants (Bredt and Snyder, 1990). Fol-
lowing incubation with cerebellar supernatants, the resin as well as the hippocampus, cortex, and cerebellum.
High-power immunohistochemical studies reveal thatwas washed extensively. As expected, a significant por-
tion of the nNOS found in the starting material was CAPON and nNOS exhibit numerous colocalizations
throughout the brain. The supraoptic nucleus stains in-bound to the resin (Figure 2D). To determine if nNOS
and CAPON were physiologically associated, we next tensely for both CAPON and nNOS (Figure 3B). The
nucleus of the trapezoid body contains CAPON-positiveassayed for CAPON bound to the resin. Like nNOS,
CAPON was substantially enriched in thebound fraction. and nNOS-positive cell bodies separated by unreactive
fascicles of nerve fibers (Figure 3B). The adjacent pon-As a control, we assayed for the resin-binding ability of
CAPON from supernatants derived from mice with a tine nucleus also exhibits CAPON and nNOS immunore-
activity of its small neuronal cell bodies (Figure 3B).genomic deletion of nNOS. These mice express a trun-
cated version of nNOS that lacks the PDZ domain and In the cerebellum, Purkinje cells fail to stain for either
CAPON or nNOS. The neuropil of the molecular cellis unable to bind CAPON. Substantially less CAPON in
these supernatants bound to the 29, 59-ADP ribose resin, layer stains intensely for both CAPON and nNOS. There
are exceptions to CAPON±nNOS colocalizations. Forindicating that CAPON has negligible intrinsic affinity for
the resin and that CAPON binding in wild-type superna- example, the granular cell layer of the cerebellum ex-
hibits strong nNOS staining but weak CAPON stainingtants was due to nNOS. The smaller cross-reactive band
was also enriched on this resin, supporting the notion (Figure 3B).
Under higher magnification, we find that CAPON, likethat it is insome manner related toCAPON by alternative
splicing or proteolytic degradation. Interestingly, the to- nNOS, is detected only in neurons, with labeling of both
the soma and processes (Figure 3B). All immunoreactiv-tal level of CAPON in knockout supernatants was ap-
proximately one half that in wild-type mice, possibly due ity is abolished by preabsorption of the CAPON antise-
rum with the antigenic peptide overnight before incuba-to the absence of a stabilizing effect of nNOS.
As a second approach, we immunoprecipitated CAPON tion with brain sections (Figure 3A).
from cerebellar supernatants and assayed for nNOS by
Western blot (Figure 2E). nNOS coprecipitates with anti-
The C Terminus of CAPON Binds to the PDZCAPON antibodies but is not detected in immunoprecip-
Domain of nNOSitates generated using preimmune serume, an antibody
To examine the region of nNOS that binds to CAPON, weto the G protein subunit b1, or with an antibody to cyclin-
conducted yeast two-hybrid experiments with variousdependent kinase 2. To determine if the enrichment ob-
truncations of nNOS (Figure 4A). As little as the first 100served in anti-CAPON immunoprecipitates was specific,
amino acids of nNOS binds to the C-terminal 125 aminowe asked if a control protein, protein kinase C-b I/II,
acids of CAPON. This portion of nNOS contains the fullwas similarly enriched in these fractions. We found that
PDZ domain as defined by MacKinnon and associatesthis protein was absent in all of the precipitates (Figure
(Doyle et al., 1996), who identified the PDZ consensus2E), indicating that the coprecipitation of nNOS with
domain in nNOS as amino acids 14±89. Deletion of theCAPON was specific. These two approaches support
first 20 amino acids of nNOS, which include the firstthe notion that CAPON and NOS exist as a complex in
seven amino acids of the PDZ domain, does not abolishthe rat cerebellum.
binding, but larger N-terminal deletions abolish binding,In other experiments, we metabolically labeled N1E-
presumably because they result in a loss of important115 mouse neuroblastoma cells with [35S]methionine
structural components of the PDZ domain. The nNOSand examined for the presence of proteins that would
construct comprising amino acids 163±245, which rep-bind to GST±CAPON. The only protein that specifically
resents the PIN-binding domain of nNOS (Jaffrey andinteracted with CAPON is a 160 kDa protein that comi-
Snyder, 1996), shows no interaction with CAPON.grates with an nNOS standard (unpublished data), sug-
PDZ domains typically interact with a characteristicgesting that nNOS is the most abundant CAPON-binding
C-terminal motif in other proteins (Songyang et al.,protein in these cells.
1997). By contrast, the nNOS PDZ domain binds directly
to other PDZ domains, such as those in PSD95, but hasCAPON and nNOS Are Colocalized in Rat Brain
not previously been reported to interact with any knownTo clarify further the relationship between nNOS and
physiological C-terminal peptide motifs. Since we couldCAPON, we compared their distributions in the brain by
not detect any PDZ domain motifs in the CAPON se-immunohistochemistry (Figures 3A and 3B). Our local-
quence, we sought to determine the region in CAPONizations of nNOS are identical to those previously re-
that accounted for nNOS binding. We investigated theported, with high levels of immunoreactivity in the ac-
cessory olfactory bulb, caudate-putamen, cerebellum, domain of CAPON that interacts with nNOS using GST±
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Figure 3. Immunohistochemical Localization
of nNOS and CAPON
(A) Comparison of nNOS IR (immunoreactiv-
ity), CAPON IR, and CAPON in situ hybridiza-
tion patterns in sagittal sections of adult rat.
Islands of Calleja (solid arrowhead); supraop-
tic nucleus (open arrowhead); AOB, acces-
sory olfactory bulb; C, colliculi; Cb, cerebel-
lum; Cx, cerebral cortex; OB, olfactory bulb.
Immunohistochemical nonspecific labeling
(Block) was determined using a CAPON anti-
body preabsorbed with the antigenic peptide.
Nonspecific hybridization (Sense) was de-
tected using a sense probe.
(B) Comparison of cellular localization of
nNOS IR and CAPON IR in adult rat brain.
(a) CAPON IR and (b) nNOS IR hypothalamic
neurons; solid arrowheads indicate IR den-
dritic processes. (c) CAPON IR and (d) nNOS
IR of the supraoptic nucleus. (e) CAPON IR
and (f) nNOS IR cell bodies of the nucleus of
the trapezoid body separated by unreactive
fascicles of nerve fibers. Adjacent is the pon-
tine nucleus (Pn), which exhibits both CAPON
and nNOS IR (e and f). (g) CAPON IR and (h)
nNOS IR in the cerebellum. Mol, molecular
cell layer; Gr, granular cell layer. Magnifica-
tion: (e) and (f), 503; (c), (d), (g), and (h), 1003;
(a) and (b), 2003.
CAPON fusion proteins containing various deletions at bind simultaneously to nNOS or whether their interac-
the C terminus (Figure 4B). Immobilized fusion proteins tions with nNOS are mutually exclusive. To answer this
were incubated with HEK-293 lysates containing nNOS. question, we incubated lysates of HEK-293 cells con-
Bound nNOS was detected by Western blot. Robust in- taining nNOS with various concentrations of a His6±
teractions with nNOS are evident with constructs con- CAPON fusion protein, comprising the last 125 amino
taining as little as the C-terminal 13 amino acids of acids of CAPON, and then added these lysates to GST±
CAPON.Deleting the C-terminal 20 amino acidsof CAPON PSD95 immobilized on glutathione agarose resin (Figure
abolishes its interactions with nNOS. These data show 5A). After extensive washing of the resin, we assayed
that the C-terminal portion of CAPON is necessary and for nNOS bound to PSD95 by Western blot. As little as
sufficient for nNOS binding. 5 nM His6±CAPON causes a substantial reduction of
Recently, Cantley and associates (Songyang et al., nNOS binding to GST±PSD95. Half-maximal reduction
1997) identified consensus sequences for binding to of binding is evident between 5 and 50 nM His6±CAPON
several PDZ domains. Binding of PDZ ligands involves (Figure 5B). Deletion of the C-terminal 20 amino acids
theC terminusof proteins, with determinantsof specific- of CAPON abolishes its ability to serve as a competitor
ity lyingwithin the eight or fewer C-terminal amino acids. for nNOS binding to GST±PSD95. As controls, we exam-
A consistent requirement among all the PDZ domain ined the effects of 5 mM His6±PIN or 5 mM His6±FK506ligands is a hydrophobic residue, such as valine or leu-
binding protein-12 (FKBP). Neither of these proteins
cine, as the final amino acid. To determine if the binding
competes for binding to nNOS. nNOS also binds to the
of CAPON to nNOSexhibits similar sequence specificity,
second PDZ domain of PSD93, a protein that is highly
we examined the binding of mutagenized His6±CAPON homologous to PSD95 (Brenman et al., 1996b). His6±fusion proteins to immobilized GST±nNOS PDZ domain
CAPON is an effective competitor for nNOS binding tofusion proteins (Figure 4C). The C-terminal residue of
immobilized GST±PSD93 as well (Figures 5A and 5B).CAPON is a valine, and conversion of this residue to
These effects of CAPON likely reflect its binding tonNOSalanine abolishes binding. Binding is also greatly re-
rather than to the PDZ domains of either PSD95 orduced by changing the penultimate amino acid from
PSD93 because CAPON fails to interact with eitheralanine to aspartate. However, changing the n-2 amino
PSD93 or PSD95 using a two-hybrid assay (see Figureacid from isoleucine to serine or alanine does not alter
1A) and in vitro experiments utilizing immobilized GST±binding. These experiments indicate that the nNOS/
PSD95 and purified recombinant CAPON (data notCAPON interaction resembles that of other PDZ/C-ter-
shown).minal peptide ligand interactions. Specifically, C-termi-
We wanted to determine if CAPON and PSD95 com-nal residues of CAPON are important for the specificity
pete for binding to nNOS in intact cells. Accordingly,in CAPON binding to nNOS.
we transfected HEK-293 cells with various mixtures of
expression plasmids containing cDNAs of hemaggluti-CAPON and PSD95 Compete for Binding to nNOS
nin antigen (HA)-tagged nNOS, myc-tagged PSD95,Since the nNOS PDZ domain is capable of both PDZ±
and/or full-length CAPON. Following immunoprecipita-PDZ interactions and PDZ/C-terminal peptide interac-
tions, we wondered whether CAPON and PSD95 can tion with antibodies to HA, we examined which proteins
Neuron
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Figure 5. CAPON and PSD95 Compete for Binding to nNOS
(A) His6±CAPON fusion proteins specifically block the nNOS/PSD95
interaction in vitro. The C-terminal 100 amino acids were fused to
a His6 tag and added to HEK-293 lysates transfected with nNOS
expression plasmids at the indicated fusion protein concentration.
This mixture was added to GST±PSD95 (amino acids 20±364) or
Figure 4. The PDZ Domain of nNOS Interacts with the C Terminus GST±PSD93 (116±421), the regions of these proteins having been
of CAPON previously shown to interact with nNOS (Brenman et al., 1996). The
disruption of the nNOS/PSD95 interaction required the C-terminal(A) The PDZ domain of nNOS (amino acids 20±100) is sufficient for
13 amino acids, as this fusion protein (DC20) fails to block thebinding to CAPON. Truncations of nNOS were subcloned into the
interaction even at 5 mM. Other control proteins such as His6-PINGAL4 BD vector, and nNOS/CAPON interactions were detected by
or His6-FKBP do not disrupt the nNOS/PSD95 interaction.b-galactosidase assays.
(B) Quantification of CAPON inhibition of the nNOS/PSD95 interac-(B) The C-terminal 13 amino acids of CAPON are sufficient for bind-
tion. HEK-293 cells were transfected with nNOS expression plas-ing to nNOS. Various GST±CAPON fusion proteins were incubated
mids and then metabolically labeled with [35S]methionine. Radiola-with HEK-293 lysates containing nNOS. A CAPON fusion protein
beled nNOS was purified and mixed with His6±CAPON as in (A),comprising the last 100 amino acids binds nNOS, as do fusion
above. Bound nNOS was resolved by electrophoresis, and countsproteins comprising the last 13 or 20 amino acids of CAPON. A
were determined on a PhosphoImager.CAPON fusion protein with the last 20 amino acids deleted no longer
binds nNOS. Neither of the control proteins GST or GST-14-3-3 is
able to bind nNOS.
that these proteins interact physiologically and that the(C) Amino acid substitutions in the C terminus of CAPON prevent it
principal biological function of CAPON may be to inter-from interacting with nNOS. His6 fusion proteins of the last 100
act with nNOS. The apparent selectivity of this interac-amino acids of CAPON were generated and incubated with GST±
NOS (1±100) immobilized on glutathione agarose. While the unmuta- tion contrasts with other nNOS-binding proteins, such
genized sequence binds (last four amino acids, EIAV), mutation of as PSD95, PIN, and calmodulin, each of which binds to
the terminal valine (EIAA) or the penultimate alanine (EIDV) prevents multiple other proteins.
binding. Serine or alanine mutations are tolerated at the n-2 position
The competitive binding for nNOS by CAPON and(ESAV and EAAV), but truncation of the C-terminal 13 amino acids
PSD95 suggests a model for regulating the translocationblocks binding altogether.
of nNOS between synaptic and nonsynaptic structures
(Figure 7). Presumably, NMDA receptor-mediated NO
release into the synaptic space must be preceded bycoprecipitated. In cells expressing HA-nNOS and myc-
PSD95, antibodies to HA coprecipitate myc-PSD95 (Fig- the translocation of nNOS to synaptic structures by
binding to PSD95. We propose that this process can beure 6). When various amounts of CAPON cDNA con-
taining expression plasmids are also transfected, HA blocked by CAPON's removal of nNOS from PSD95 and
translocating nNOS into the cytoplasm or some otherimmunoprecipitates contain CAPON but substantially
less PSD95. cellular compartment. In this manner, CAPON could lead
to effective nNOS inhibition. Although CAPON does not
inhibit nNOS catalytic activity directly (data not shown),Discussion
CAPON would reduce the accessibility of nNOS to
NMDA receptor-mediated calcium influx, thus diminish-The main finding of this study is the identification of a
novel protein, CAPON, which interacts selectively with ing the capacity of nNOS to exert its physiologic or
pathologic effects. Small molecules that specificallynNOS. The interaction of CAPON with nNOS is highly
specific and has been verified by several methods of bind to nNOS in a manner similar to that of CAPON may
be useful for blocking NO-mediated neuronal degener-monitoring protein±protein interactions. The similarities
in neuronal localizations of CAPON and nNOS imply ation.
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Figure 7. Model of PSD95/nNOS Regulation by CAPON
NMDA receptors are coupled to nNOS through a PSD95 multimer.
These interactions are mediated by PDZ domains. In this complex,
Figure 6. CAPONExpression Prevents the Interaction of PSD95 and nNOS is situated close to NMDA receptor-modulated calcium influx
nNOS (left). Binding of CAPON (right) results in a reduction of NMDA recep-
HEK-293 cells were transfected with various combinations of ex- tor/PSD95/nNOS complexes, leading to decreased access to NMDA
pression plasmids for HA-tagged nNOS (HA-NOS), myc-tagged receptor-gated calcium influx and a catalytically inactive enzyme.
PSD95, or CAPON.Following transfection, the lysates were immuno-
precipitated with an anti-HA antibody, and bound proteins were
detected with the appropriate antibodies. Following cotransfection
of HA-NOS and myc-PSD95, myc-PSD95 is detected in anti-HA active in the nanomolar range (see Figure 5). Peptide
immunoprecipitates. Cotransfection of a full-length CAPON expres- competitors that interact with other PDZ domains have
sion plasmid substantially reduces the amount of myc-PSD95 in also been utilized at 10 and 500 mM concentrations (see
anti-HA precipitates. In the absence of HA-nNOS transfection, nei-
Brenman et al., 1996a; Kornau et al., 1995). Conceivably,ther myc-PSD95 or CAPON is immunoprecipitated by anti-HA anti-
the nNOS/CAPON interaction would be disrupted simplybodies.
by disrupting the b-sheet conformation of the C termi-
nus, which might be achieved by phosphorylation at a
distance.We have explored potential mechanisms that might
The nNOS PDZ domain isan example of a PDZ domainregulate the nNOS/CAPON interaction. For instance, we
that binds to other PDZ domains. The region of nNOSphosphorylated nNOS in transfected HEK-293 cells by
that possesses this property is the PDZ domain plustreatment with forskolin, phorbol esters, dibutyryl cyclic
the adjacent z50 amino acids on the C side of the PDZAMP, and 8-bromo-cyclic GMP and in vitro with purified
domain (residues 1±150) (Brenman et al., 1996b). ThenNOS protein utilizing protein kinase C, protein kinase
additional amino acids in this super-sized PDZ domainA, and calcium/calmodulin-dependent protein kinase
may be required to accomodate larger ligands such asusing methods described previously (Bredt et al., 1992).
other PDZ domains. The finding in this report of anotherWe have been unable to alter CAPON/nNOS interactions
physiologic ligand for the PDZ domain, namely, theby any of these treatments (unpublished data).
C-terminal region of CAPON, raises the question ofConceivably, phosphorylation of CAPON regulates its
whether the same or different portions of the nNOS PDZinteractions with nNOS. Recently, some of us showed
domain account for the binding to two seemingly differ-that phosphorylation of the n-2 serine in the potassium
ent ligands. Because these interactions are mutuallychannel BIRK-2 regulates its binding to a PDZ domain
exclusive, it is likely that the ligand-binding cleft in thein PSD95 (Cohen et al., 1996). CAPON and several other
PDZ domain mediates both interactions. PreviouslyPDZ domain ligands (Songyang et al., 1997) lack a serine
identified proteins that contain C-terminal PDZ-bindingin this position and so must be regulated in some other
sequences have been membrane-associated. By con-manner. One possible mechanism may be a regulation
trast, CAPON is soluble. This demonstrates that PDZof the ligand's C-terminal secondary structure. A recent
domains may mediate purely cytosolic protein±proteincrystallographic study of a PDZ domain complexed with
interactions.a short cognate peptide shows that the peptide binds
Stricker et al. (1997) recently characterized the speci-inan antiparallel b-sheet conformation,with characteris-
ficity ofthe nNOS PDZ-binding domain.These researcherstic b-sheet contacts between the peptide and a strand
used a phage display method to identify NOS-bindingof a b sheet within the PDZ domain (see Doyle et al.,
peptides. Peptides ending in the sequence aspartate-1996). In a physiologic setting, the unbound cognate
X-valine were found to be high-affinity ligands. Interest-sequence may constitutively adopt a b-sheet conforma-
ingly, unlike CAPON, these peptides did not bind thetion, with the other b strands coming from other, possi-
canonical nNOS PDZ domain (amino acids 13±89) butbly distant, residues within the ligand protein's se-
bound the extended PDZ domain only (aminoacids1±150).quence. This b sheet might constitute an endogenous
This extended domain is the minimal sequence that me-high-affinity ligand. This notion is supported by our ob-
diates PDZ±PDZ interactions. Presumably, the differ-servation that short, presumably unfolded, peptides
ences in the binding sites in nNOS for the phage displaycomprising the C-terminal nine residues of CAPON bind
peptide and CAPON account for the differences be-nNOS weakly, while 16 residue peptides are more potent
tween the sequence specificity requirements for PDZ±competitors (IC50 5 10 mM), although both are much less
effective than 100 amino acid fusion proteins that are PDZ interactions and PDZ±CAPON interactions.
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Experimental Procedures buffer (50 mM Tris-HCl [pH 7.7], 100 mM NaCl, 10 mM reduced
glutathione, and 2 mM EDTA).
Transfections were performed with 10 mg of each plasmid usingGeneral Methods and Materials
Molecular biology reagents were from New England Biolabs (Bev- the calcium phosphate method. Following transfection, cells were
sonicated in buffer A (50 mM Tris-HCl [pH 7.7], 100 mM NaCl, 2 mMerly, MA) and all other reagents were from Sigma (St. Louis, MO)
except as indicated. Protein concentrations were determined by EDTA, and 1% Triton X-100) and cleared by centrifugation. This
cellular lysate was incubated with GST fusion protein immobilizedBradford assay.
on glutathione agarose for 1 hr at 48C and washed extensively in
HNTG buffer (20 mM HEPES [pH 7.4], 500 mM NaCl, 10% glycerol,Yeast Two-Hybrid Methods
and 0.1% Triton X-100) five times, for 10 min per wash at roomTwo-hybrid screens and the construction of the parent vectors
temperature. A GST±CAPON fusion protein consisting of aminopPC86, containing the GAL4 activation domain, and pPC97, con-
acids 379±503 was used for binding assays because it was moretaining the GAL4 DNA-binding domain, have been described (Jaffrey
soluble when expressed in bacteria than larger CAPON fusion pro-and Snyder, 1996). Plasmid pBD-NOS(2±377) was prepared by the
teins.insertion of an nNOS PCR product corresponding to amino acids
For quantitative binding experiments, transfected cells were met-2±377 of rat nNOS into the SalI and BglII sites of pPC97, resulting
abolically labeled overnight with 200 mCi [35S]methionine, and nNOSin an open reading frame encoding a GAL4 BD-NOS fusion protein
was purified by NADPH elution of 29,59-ADP ribose as described(Jaffrey and Snyder, 1996). The nNOS fragment was constructed by
previously (Bredt and Snyder, 1990).PCR using the followingprimers: 59-GACTAGTCGACTGAAGAGAAC
The material remaining on the resin was eluted with SDS-PAGEACGTTTGGG-39 (coding strand) and 59-TCTGCAGATCTCAGTGGG
sample buffer, and nNOS was detected by immunoblot using anti-CCTTGGAGCCAAA-39 (noncoding strand).
bodies specific to each NOS isoform (Transduction Labs). A poly-A rat hippocampal cDNA library in pPC86 (Li et al., 1995) was
clonal antiserum to CAPON was generated in rabbits by using aamplified once in DH10B (GIBCO BRL) as described (Jaffrey and
His6-tagged CAPON fusion protein. GST±CAPON was crosslinkedSnyder, 1996) and transformed into yeast containing the pBD-
to glutathione agarose with dimethylpimelimidate, and this resinNOS(2±377) plasmid. pAD-CAPON1 and pAD-CAPON2 were identi-
was used to purify CAPON antibody. To confirm the specificity of thefied as 0.8 kb and 1.9 kb clones, respectively, that activated lacZ
antibody, immune serum was incubated with His6±CAPON, whichtranscription and conferred histidine prototrophy in the presence of
results in the abolishment of the signal. Incubation with His6-FKBPpBD-NOS(2±377). Plasmids were sequenced by automated fluores-
has no effect on the signal (data not shown).cent sequencing of both strands. Yeast two-hybrid vectors con-
For blot-overlay analysis, CAPON was inserted into pGEX-4T2, ataining the second PDZ domain of PSD93 (amino acids 116±421)
derivative of PGEX4T2 in which two cyclic AMP-dependent proteinand the three PDZ domains of PSD95 (amino acids 20±364) have
kinase (PKA) sites were inserted between the GST moiety and thebeen described previously (Brenman et al., 1996a).
multiple cloning site (Jaffrey and Snyder, 1996). Kinase reactionsTruncated NOS fragments comprising amino acids 2±165 and
and blot overlays were performed as described (Kavanaugh and2±284 were generated by restriction of the initial NOS (2±377) PCR
Williams, 1994).fragment with NcoI and AvaI, respectively, followed by Klenow filling
in of that end and ligation into pPC97. Other truncated NOS frag-
Immunoprecipitationsments were prepared by PCR and have been described (Jaffrey and
Immunoprecipitations wereperformed by homogenizing one rat cer-Snyder, 1996).
ebellum in 3 ml of lysis buffer followed by centrifugation at 100,000 3
g for 30 min at 48C. Two hundred microliters of the supernatant was
Cloning of CAPON cDNA
incubated with 40 ml of protein A-agarose (Oncogene Sciences,
A CAPON DNA probe was generated by the random hexamer
Cambridge, MA) and 5 mg of the indicated antibody for 60 min at
method using the pAD-CAPON2 cDNA as a template. This probe
48C. The resins were then washed with IP wash buffer (50 mM Tris-
was used to screen a rat brain lZAPII cDNA library (Stratagene)
HCl [pH 7.7], 400 mM NaCl, and 2 mM EDTA) six times and eluted
using methods described by the manufacturer. A 2.1 kb cDNA was
in 60 ml of 13 SDS-PAGE sample buffer by boiling. Western blots
isolated that overlapped with the pAD-CAPON2 clone. The cDNAs
were performed using an nNOS-specific monoclonal antibody
were ligated at an overlapping XbaI site to produce the full-length
(Transduction Labs) or a PKC-b I/II monoclonal antibody (Santa
2,812 bp cDNA and subcloned into pCMV for eukaryotic expression.
Cruz Biotechnology, Santa Cruz, CA).The immunoprecipitating anti-
The human CAPON EST was the sole CAPON homolog identified
bodies used as controls were from Santa Cruz Biotechnology.
in a BLAST seacrh (Altschul et al., 1990). I.M.A.G.E. consortium
For experiments utilizing 29,59-ADP-Sepharose (Pharmacia), tis-
(http://www.bio.llnl.gov/bbrp/image/image.html/) clone 34183 (Lennon
sues were prepared identically as for immunoprecipitations, except
et al., 1996) was purchased from Research Genetics (Huntsville, AL). mouse cerebella were used, and the homogenization volume was
400 ml per cerebellum. Supernatants were incubated with 100 ml of
RNA (Northern) Blotting affinity resin. Incubations and washes were performed identically
Thirty micrograms of whole RNA was isolated from rat tissues using as for immunoprecipitations. The generation of mice with a targeted
the Triazol reagent (GIBCO BRL) and separated on agarose-formal- deletion of nNOS has been described previously (Huang et al., 1993).
dehyde gels. RNA was transferred to Hybond N1 membranes (Amer-
sham), and a DNA probe, generated using the random hexamer Immunohistochemistry
method with the two-hybrid CAPON cDNA as a template, was hy- Adult Sprague-Dawley rats (200±250 g) were obtained from Charles
bridized in Rapid-hyb buffer (Amersham) overnight at 658C. The River and housed at the Johns Hopkins Animal Care Facility. A
blots were subsequently washed sequentially in 23 SSC with 0.1% polyclonal antiserum to the C-terminal region of human nNOS (resi-
SDS, once at room temperature for 15 min, 13 SSC with 1% SDS dues 1419±1433) was kindly provided by J. Spangenberg (IncStar,
twice at 658C, 0.13 SSC with 1% SDS twice at 658C, and then with Stillwater, MN). The peroxidase Elite staining kit was from Vector
0.13 SSC with 5% SDS twice at 658C. The blot was apposed to film Laboratories.
for 4 days at 2808C to visualize the bands. Anesthetized rats were perfused through the left ventricle with 50
ml of 0.9% NaCl followed by 500 ml of 4% paraformaldehyde in 0.1
M phosphate buffer (PB) (pH 7.4). The brains were removed, cutGST Fusion Protein Binding Assays
GST fusion proteins were prepared in BL21(DE3) Escherichia coli into saggital blocks, and postfixed in 4% paraformaldehyde in 0.1
M PB for 4 hr at room temperature. Blocks were cryoprotected for(Novagen) with glutathione agarose as an affinity resin for purifica-
tion (Smith and Johnson, 1988), except that bacterial pellets were 2 days at 48C in 50 mM sodium phosphate (pH 7.4)/0.1 M NaCl/20%
(v/v) glycerol. Brain sections, 40 mm thick, were cut on a slidingsonicated in lysis buffer (50 mM Tris-HCl [pH 7.7], 100 mM NaCl,
and 2 mM EDTA), supernatants were adjusted to 1% Triton X-100, microtome. Free-floating sections were incubated in PBS (10 mM
[pH 7.4]/0.19 M NaCl) containing 4% normal goat serum (Jacksonwashes were done in 50 mM Tris-HCl (pH 7.7), 500 mM NaCl, 2 mM
EDTA, and 1% Triton X-100, and protein was purified with elution Labs) and 0.2%Triton X-100 for 45 min andthen incubated overnight
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at 48C with the primary antiserum diluted 1:500 (CAPON) or 1:15,000 Doyle, D.A., Lee, A., Lewis, J., Kim, E., Sheng, M., and MacKinnon,
R. (1996). Crystal structures of a complexed and peptide-free mem-(nNOS) in phosphate-buffered saline (PBS) containing 2% goat se-
rum and 0.1% Triton X-100. Immunoreactivity was visualized with brane protein-binding domain: molecular basis of peptide recogni-
tion by PDZ. Cell 85, 1067±1076.the Vectastain ABC Elite kit following the nickel-enhanced diamino-
benzidine procedure. To test immunohistochemical specificity of Garthwaite, J., Garthwaite, G., Palmer, R.M.J., and Moncada, S.
the CAPON antiserum, the antiserum was incubated overnight with (1989). NMDA receptor activation induces nitric oxidesynthesis from
13.5 mg/ml of the antigenic fusion protein before incubation with arginine in rat brain slices. Eur. J. Pharmacol. 172, 413±416.
brain sections. Hecker, M.,Mulsch, A., and Busse, R. (1994). Subcellular localization
and characterization of neuronal nitric oxide synthase. J. Neuro-
In Situ Hybridization chem. 62, 1524±1529.
In situ hybridization used DNA oligonucleotide probes correspond-
Huang, E.P. (1997). Synaptic plasticity: a role for nitric oxide in LTP.ing to amino acids 478±503. Probes were end labeled with
Curr. Biol. 7, R141±143.[a-32P]dATP and terminal deoxynucleotidyl transferase to a specific
Huang, P.L., Dawson, T.M., Bredt, D.S., Snyder, S.H., and Fishman,activity of 800 mCi/mg, and in situ hybridization was performed as
M.C. (1993). Targeted disruption of the neuronal nitric oxide syn-described previously (Jaffrey et al., 1994). Nonspecific hybridization
thase gene. Cell 75, 1273±1286.was determined using the corresponding sense probe.
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